Skip to main content

Drug Interactions between cefuroxime and disulfiram

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

cefuroxime disulfiram

Applies to: cefuroxime and disulfiram

MONITOR: An isolated case report suggests that the disulfiram reaction can occur during coadministration of cefuroxime axetil. Because the axetil moiety is metabolized to acetaldehyde in vivo, the reaction was presumably caused by an accumulation of acetaldehyde in the presence of disulfiram, which blocks the conversion of acetaldehyde to acetate. High levels of acetaldehyde can produce an unpleasant physiologic response referred to as the 'disulfiram reaction'. Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion. Severe reactions may result in respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death. In the report, a patient who had been receiving disulfiram 125 mg every morning for the previous 18 months developed nausea, vomiting, and stomach cramps within one hour after a 250 mg oral dose of cefuroxime. These symptoms lasted eight to nine hours. The patient was not rechallenged.

MANAGEMENT: Until more information is available, the possibility of a disulfiram reaction should be considered when prescribing cefuroxime axetil to patients treated with disulfiram.

References (2)
  1. (2002) "Product Information. Ceftin (cefuroxime)." Glaxo Wellcome
  2. Mattes JA (2006) "Antabuse reaction with ceftin." Am J Psychiatry, 163, p. 2019-20

Drug and food interactions

Major

disulfiram food

Applies to: disulfiram

CONTRAINDICATED: Consumption of ethanol during treatment with disulfiram may cause flushing, nausea, blurred vision, dyspnea, tachypnea, tachycardia, and hypotension. Death has been reported. The mechanism is probably related to inhibition of aldehyde dehydrogenase, the enzyme responsible for the oxidation of acetaldehyde to acetyl CoA. Accumulation of acetaldehyde probably results.

MANAGEMENT: Ethanol should be avoided in patients receiving disulfiram.

References (3)
  1. Jones RO (1949) "Death following the ingestion of alcohol in an antabuse treated patient." Can Med Assoc J, 60, p. 609-12
  2. Stoll D, King LE (1980) "Disulfiram-alcohol skin reaction to beer-containing shampoo." JAMA, 244, p. 2045
  3. van Ieperen L (1984) "Sudden death during disulfiram-ethanol reaction." S Afr Med J, 66, p. 165

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.